- Report
- February 2026
- 182 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- January 2026
- 149 Pages
Global
From €3459EUR$3,950USD£3,003GBP
- Report
- July 2025
- 350 Pages
Global
From €4334EUR$4,949USD£3,762GBP
- Report
- July 2025
- 140 Pages
Global
From €4248EUR$4,850USD£3,687GBP
- Report
- August 2025
- 188 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- August 2025
- 189 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- February 2026
- 383 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- September 2025
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- September 2025
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- July 2025
- 175 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- September 2025
- 150 Pages
Global
From €3897EUR$4,450USD£3,383GBP
- Report
- September 2025
- 150 Pages
Global
From €3372EUR$3,850USD£2,927GBP
€4248EUR$4,850USD£3,687GBP
- Report
- July 2025
- 112 Pages
Global
From €3500EUR$4,281USD£3,144GBP
- Report
- June 2025
- 300 Pages
Latin America
From €3389EUR$3,869USD£2,941GBP
- Report
- February 2024
- 202 Pages
Global
From €4379EUR$5,000USD£3,801GBP
- Report
- November 2023
- 124 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- January 2023
- 124 Pages
Global
From €1971EUR$2,250USD£1,710GBP
- Report
- January 2024
- 213 Pages
Global
From €4073EUR$4,650USD£3,535GBP
- Report
- January 2024
- 200 Pages
Global
From €3635EUR$4,150USD£3,155GBP
- Report
- August 2023
- 145 Pages
Global
From €2759EUR$3,150USD£2,395GBP

The Hepatitis B Vaccine market is a subset of the larger Infectious Disease Testing market. It is focused on the prevention of Hepatitis B, a viral infection that can cause serious liver damage. The vaccine is typically administered to infants and young children, as well as adults at risk of infection. The vaccine is also recommended for healthcare workers and those with multiple sexual partners. The market is driven by the need to protect vulnerable populations from the virus, as well as the increasing prevalence of the disease in certain regions.
Companies in the Hepatitis B Vaccine market include GlaxoSmithKline, Merck & Co., Sanofi Pasteur, and Pfizer. Show Less Read more